| Accession | Acc. Gene-, Name | Start | End | Subsequence | Logic | PDB | Organism | Length | 
|---|---|---|---|---|---|---|---|---|
| ELMI002399 |  P38398 BRCA1 BRCA1_HUMAN  | 
        504 | 509 | PLTNKLKRKRRPTSGLHPED | TP | --- | Homo sapiens (Human) | 1863 | 
  Instance evidence
| Evidence class | PSI-MI | Method | BioSource | PubMed | Logic | Reliability | Notes | 
|---|---|---|---|---|---|---|---|
| experimental | MI:0018 | two hybrid | in vivo | Chen,1996 | support | certain | InteractionDetection | 
| experimental | MI:0403 | colocalization | in vitro | Chen,1996 | support | certain | |
| experimental | MI:0074 | mutation analysis | in vivo/in vitro | Chen,1996 | support | certain | FeatureDetection | 
  Switches 
 This ELM instance is part of the following 1 switching mechanism annotated at the switches.ELM resource:
    
    - 
        SWTI000580:
Alternative splicing removes the nuclear localisation signal (NLS) of Breast cancer type 1 susceptibility protein (BRCA1), abrogating binding to Importin subunit alpha-1 (KPNA1) and import into the nucleus. The study compared the full-length Brca1 splice variant (Isoform 1) to the Delta11b isoform (Isoform Delta11b). The shorter isoform is missing exon 11b and differs in a number of ways. Firstly, it lacks an NLS and therefore has a cytoplasmic localisation. Also, when over-expressed, the Delta11b isoform was not toxic, suggesting nuclear localisation is important for Brca1\'s toxic behaviour.
 
  Pathways 
    
        Please cite: 
            ELM-the Eukaryotic Linear Motif resource-2024 update.
        
    (PMID:37962385)
    
    
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
